20 results
8-K
EX-10.4
NTBL
Notable Labs Ltd
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
of confidentiality obligations, claims or demands in regard of invasion of privacy including with respect to databases, claims, demands or acts in connection
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
will be subject to applicable anti-kickback, fraud and abuse, false claims, transparency, health information privacy and security, and other healthcare laws … Notable obtain marketing approval. In addition, Notable may be subject to transparency laws and patient privacy regulation by U.S. federal and state
S-4/A
06eoll gi4na
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
zj5eiqemz
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
6cxunayupj 2l
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.14
et5nd xi5pfj
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
3pl07wba69tgsov162
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.15
1u0j4crm3jo6
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
ez1vaid 9dvz1r
11 Feb 22
Current report (foreign)
5:29pm
6-K
EX-1.1
ltmedqbl
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
20-F
EX-4.18
d0jr9g tmvh76mgmrwl
25 Mar 15
Annual report (foreign)
12:00am
F-1/A
EX-10.11
s48gczba7k6xnwsb3pg
18 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next